InvestorsHub Logo
Followers 11
Posts 5005
Boards Moderated 0
Alias Born 11/14/2009

Re: MSU post# 1066

Wednesday, 08/29/2018 4:19:21 PM

Wednesday, August 29, 2018 4:19:21 PM

Post# of 1448
Read.what the.company says!NO product.until.2020!! That is IF you even believe their time lines which have greatly revised! They always miss their time frames by like 100%. I expect the "verified unit" they need to do the FDA trial to be finished mid-to late 2019. Then the FDA trial can start in 2020 and wrap up by early 2021. Then the data has to be submitted to the FDA for approval. Thats like another 1-2 years IF things even go well in the trial. Voila you are now in the year 2023! The fact is the company only has like $6 million and cannot last the next 4.5 years with the money they have. Sell now my friends. In my opinion! MY BOLDING below >>>>>>>>>>>>>>>>

"Based on progress made to-date, the Company currently expects the completion of the Functional Unit phase in calendar 4Q 2018 and the Verified Unit phase in calendar 1Q 2019. The Company believes that the miniaturization, imaging quality and cost reduction goals for the i/Blue Imaging System will be achieved as Optel optimizes the system and works toward commercialization."

"Necessary documents to begin the FDA process, including clinical study recommendation, are being prepared for submission. The timing of the clinical studies is tied to the final verification of the i/Blue Imaging System and is currently anticipated to begin late calendar 1Q 2019 or during calendar 2Q 2019. Depending on the FDA device classification and schedule, the Company is planning for potential commercialization in calendar year 2020."